These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9531002)

  • 1. Pathological versus physiological left ventricular hypertrophy: a review.
    Richey PA; Brown SP
    J Sports Sci; 1998 Feb; 16(2):129-41. PubMed ID: 9531002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.
    Frohlich ED; González A; Díez J
    J Hypertens; 2011 Jan; 29(1):17-26. PubMed ID: 21045723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ventricular hypertrophy as an expression of hypertensive damage].
    Chiariello M; Betocchi S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):79-84. PubMed ID: 1841809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concept of cardioreparation: Part 1. Pathophysiology of remodelling.
    Brilla CG; Murphy RL; Smits JF; Struijker Boudier HA; Tan LB
    J Cardiovasc Risk; 1996 Jun; 3(3):281-5. PubMed ID: 8863100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease].
    Funck RC; Wilke A; Rupp H; Maisch B; Brilla CG
    Herz; 1995 Oct; 20(5):330-9. PubMed ID: 7498880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non invasive approach to differentiate physiological versus pathological left ventricle hypertrophy.
    Bayes de Luna A
    J Med Liban; 1999; 47(3):190-3. PubMed ID: 10550945
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial structure and left ventricular function in hypertrophic and dilative cardiomyopathy and aortic valve disease.
    Kunkel B; Schneider M
    Z Kardiol; 1987; 76 Suppl 3():9-13. PubMed ID: 3433878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications.
    Devereux RB; de Simone G; Ganau A; Roman MJ
    J Hypertens Suppl; 1994 Dec; 12(10):S117-27. PubMed ID: 7769482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphologic aspects of the left ventricular remodeling in hypertensive cardiomyopathy].
    Mandarim-de-Lacerda CA
    Arq Bras Cardiol; 1995 Dec; 65(6):523-7. PubMed ID: 8731308
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study.
    Bacharova L; Szathmary V; Kovalcik M; Mateasik A
    J Electrocardiol; 2010; 43(3):200-8. PubMed ID: 19709670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved cardiac performance with reduced left ventricular mass in conscious exercising spontaneously hypertensive rats.
    Soria F; Frohlich ED; Aristizabal D; Kaneko K; Kardon M; Hunter J; Pegram B
    J Hypertens; 1994 May; 12(5):585-9. PubMed ID: 7930559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.